Prabha Hullatti

Mrs. Prabha Hullatti


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2025 in International Journal of Pharmacy and Pharmaceutical Sciences
Verified
Journal Article
Open access
PHPrabha Hullatti
Prabha Hullatti
PHPrabha Hullatti
Prabha Hullatti
NMNabarun Mukhopadhyay
Nabarun Mukhopadhyay
ABA. P. Basavarajappa
A. P. Basavarajappa
SPSaraswati Patel
Saraswati Patel
Inflammatory Bowel Disease (IBD) is a chronic disorder caused due to several factors. Out of these, inflammation is one of the major causative factors, and several inflammatory markers, like pro-inflammatory cytokines enzymes play an essential role in the progression and development of IBD. The existing therapies against IBD have severe adverse effects, and drug resistance can also occur. Hence, novel therapies against IBD need to be developed for the treatment and prevention of IBD. Natural products, specifically flavonoids, can be an excellent alternative to get better therapeutic efficacy. Hence, flavonoids can be utilized more bitterly as a drug candidate for IBD. Our review work mainly discussed the potential flavonoids and their role in treating IBD and also focussed on it by inhibiting inflammatory markers.

1 July 2026 in Chemistry Africa
Verified
Journal Article
Closed access
PDF file
SFSamriti Faujdar
Samriti Faujdar
PHPrabha Hullatti
Prabha Hullatti
ABA. P. Basavarajappa
A. P. Basavarajappa
TSThippeswamy Boreddy Shivanandappa
Thippeswamy Boreddy Shivanandappa
NMNabarun Mukhopadhyay
Nabarun Mukhopadhyay